Pharmaceutical

‘Robbing Peter to pay Paul’: Obesity experts debate risks of new weight loss drugs

‘Robbing Peter to pay Paul’: Obesity experts debate ris...

May 9, 2023

Amid rising demand for drugs like Wegovy and Ozempic that can lead to significan...

U.S. backs study of safe injection sites, overdose prevention

U.S. backs study of safe injection sites, overdose prev...

May 9, 2023

For the first time, the U.S. government will pay for a large study measuring whe...

Rare-disease doctors support expanded newborn genomic screening, survey finds

Rare-disease doctors support expanded newborn genomic s...

May 9, 2023

There is emerging consensus among rare-disease physicians that genomic sequencin...

STAT+: Cracking an intriguing secret of centenarians: Why so few are ravaged by Alzheimer’s disease

STAT+: Cracking an intriguing secret of centenarians: W...

May 9, 2023

Major age-related illnesses hit most centenarians about 20 to 30 years later tha...

STAT+: Pharmalittle: FDA panel to review over-the-counter birth control pill; Alzheimer’s drugs may lead to haves and have-nots

STAT+: Pharmalittle: FDA panel to review over-the-count...

May 9, 2023

An FDA advisory panel will meet this week to review an application by Perrigo to...

Opinion: The amoxicillin shortage continues to force pediatricians and families to scramble

Opinion: The amoxicillin shortage continues to force pe...

May 9, 2023

What will happen should we see a repeat of the tripledemic this upcoming winter?

Leading innovators in anti-influenza antibody compositions for the pharmaceutical industry

Leading innovators in anti-influenza antibody compositi...

May 8, 2023

The pharmaceutical industry continues to be a hotbed of innovation, with activit...

Leading innovators in anti-inflammatory anaesthetics for the pharmaceutical industry

Leading innovators in anti-inflammatory anaesthetics fo...

May 8, 2023

The pharmaceutical industry continues to be a hotbed of innovation, with activit...

Eisai signs agreement with Bliss Biopharmaceutical to develop BB-1701

Eisai signs agreement with Bliss Biopharmaceutical to d...

May 8, 2023

Eisai will also get rights to develop and commercialise BB-1701 across the world...

Junshi Biosciences, Dr. Reddy’s partner to develop and market toripalimab

Junshi Biosciences, Dr. Reddy’s partner to develop and ...

May 8, 2023

Dr. Reddy’s may choose to license toripalimab in New Zealand, Australia, as well...

Innovation in immuno-oncology: Leading companies in monoclonal antibody conjugates for cancer treatment

Innovation in immuno-oncology: Leading companies in mon...

May 8, 2023

The pharmaceutical industry continues to be a hotbed of innovation, with activit...

Leading innovators in zinc-finger nucleases for the pharmaceutical industry

Leading innovators in zinc-finger nucleases for the pha...

May 8, 2023

The pharmaceutical industry continues to be a hotbed of innovation, with activit...

Leading innovators in zinc-based medicinal compositions for the pharmaceutical industry

Leading innovators in zinc-based medicinal compositions...

May 8, 2023

The pharmaceutical industry continues to be a hotbed of innovation, with activit...

Leading innovators in ssRNA virus peptides for the pharmaceutical industry

Leading innovators in ssRNA virus peptides for the phar...

May 8, 2023

The pharmaceutical industry continues to be a hotbed of innovation, with activit...

Innovation in immuno-oncology: Leading companies in microbiota restoration therapy

Innovation in immuno-oncology: Leading companies in mic...

May 8, 2023

The pharmaceutical industry continues to be a hotbed of innovation, with activit...

Leading innovators in anti-viral antigen-based compositions for the pharmaceutical industry

Leading innovators in anti-viral antigen-based composit...

May 8, 2023

The pharmaceutical industry continues to be a hotbed of innovation, with activit...